The Singh brothers have once again proved that they are true businessmen. When they saw that the path for Indian pharmaceuticals firms was riddled with problems, they were quick to exit at a huge profit by selling Ranbaxy to Daiichi of Japan — later, others like the Piramals did the same. Now, after announcing that Parkway would be their vehicle to expand the hospital business in South-east Asia, when they saw a big profit, they decided to sell and made around Rs 400 crore in the bargain.
This is the difference between an entrepreneur and a businessman — an entrepreneur gets so involved in her business, she is unable to exit even when the price is right; a businessman is rational and looks at how many years it would take for the business to make those kind of profits and then takes a call.
Ajay Srivastava, New Delhi
Readers should write to:
The Editor, Business Standard,
Nehru House, 4, Bahadur Shah Zafar Marg,
New Delhi 110 002,
Fax: (011) 23720201;
letters@bsmail.in
